These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25005574)

  • 21. Cognitive features 10 or more years after successful breast cancer survival: comparisons across types of cancer interventions.
    Nguyen CM; Yamada TH; Beglinger LJ; Cavanaugh JE; Denburg NL; Schultz SK
    Psychooncology; 2013 Apr; 22(4):862-8. PubMed ID: 22585465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Pilot Study of a Cognitive-Behavioral Intervention for Breast Cancer Survivors.
    Becker H; Henneghan AM; Volker DL; Mikan SQ
    Oncol Nurs Forum; 2017 Mar; 44(2):255-264. PubMed ID: 28222075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropsychological outcomes of older breast cancer survivors: cognitive features ten or more years after chemotherapy.
    Yamada TH; Denburg NL; Beglinger LJ; Schultz SK
    J Neuropsychiatry Clin Neurosci; 2010; 22(1):48-54. PubMed ID: 20160209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.
    Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB
    J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brief self-report measure of work-related cognitive limitations in breast cancer survivors.
    Ottati A; Feuerstein M
    J Cancer Surviv; 2013 Jun; 7(2):262-73. PubMed ID: 23552976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive functioning after cancer treatment: a 3-year longitudinal comparison of breast cancer survivors treated with chemotherapy or radiation and noncancer controls.
    Phillips KM; Jim HS; Small BJ; Laronga C; Andrykowski MA; Jacobsen PB
    Cancer; 2012 Apr; 118(7):1925-32. PubMed ID: 22161750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.
    Ahles TA; Saykin AJ; Furstenberg CT; Cole B; Mott LA; Skalla K; Whedon MB; Bivens S; Mitchell T; Greenberg ER; Silberfarb PM
    J Clin Oncol; 2002 Jan; 20(2):485-93. PubMed ID: 11786578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients.
    Jansen CE; Cooper BA; Dodd MJ; Miaskowski CA
    Support Care Cancer; 2011 Oct; 19(10):1647-56. PubMed ID: 20820813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurological complications of breast cancer: A prospective cohort study.
    Pereira S; Fontes F; Sonin T; Dias T; Fragoso M; Castro-Lopes JM; Lunet N
    Breast; 2015 Oct; 24(5):582-7. PubMed ID: 26096894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of long-term fatigue in breast cancer survivors: results of a prospective patient cohort study.
    Schmidt ME; Chang-Claude J; Seibold P; Vrieling A; Heinz J; Flesch-Janys D; Steindorf K
    Psychooncology; 2015 Jan; 24(1):40-6. PubMed ID: 24839264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trajectories of self-reported cognitive function in postmenopausal women during adjuvant systemic therapy for breast cancer.
    Merriman JD; Sereika SM; Brufsky AM; McAuliffe PF; McGuire KP; Myers JS; Phillips ML; Ryan CM; Gentry AL; Jones LD; Bender CM
    Psychooncology; 2017 Jan; 26(1):44-52. PubMed ID: 26486371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive effects of adjuvant endocrine therapy in older women treated for early-stage breast cancer: a 1-year longitudinal study.
    Underwood EA; Jerzak KJ; Lebovic G; Rochon PA; Elser C; Pritchard KI; Tierney MC
    Support Care Cancer; 2019 Aug; 27(8):3035-3043. PubMed ID: 30610433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up.
    Douw L; Klein M; Fagel SS; van den Heuvel J; Taphoorn MJ; Aaronson NK; Postma TJ; Vandertop WP; Mooij JJ; Boerman RH; Beute GN; Sluimer JD; Slotman BJ; Reijneveld JC; Heimans JJ
    Lancet Neurol; 2009 Sep; 8(9):810-8. PubMed ID: 19665931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DIVERGT screening procedure predicts general cognitive functioning in adult long-term survivors of pediatric acute lymphoblastic leukemia: A PETALE study.
    Boulet-Craig A; Robaey P; Laniel J; Bertout L; Drouin S; Krajinovic M; Laverdière C; Sinnett D; Sultan S; Lippé S
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27259. PubMed ID: 29797640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mindfulness-based interventions and cognitive function among breast cancer survivors: a systematic review.
    Cifu G; Power MC; Shomstein S; Arem H
    BMC Cancer; 2018 Nov; 18(1):1163. PubMed ID: 30477450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Web-based cognitive training for breast cancer survivors with cognitive complaints-a randomized controlled trial.
    Damholdt MF; Mehlsen M; O'Toole MS; Andreasen RK; Pedersen AD; Zachariae R
    Psychooncology; 2016 Nov; 25(11):1293-1300. PubMed ID: 26763774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late Effects of Breast Cancer Treatment and Outcome after Corrective Interventions.
    Pillai US; Kayal S; Cyriac S; Nisha Y; Dharanipragada K; Kamalanathan SK; Halanaik D; Kumar N; Madasamy P; Muniswamy DK; Dubashi B
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2673-2679. PubMed ID: 31554363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive impairment associated with adjuvant therapy in breast cancer.
    Bender CM; Sereika SM; Berga SL; Vogel VG; Brufsky AM; Paraska KK; Ryan CM
    Psychooncology; 2006 May; 15(5):422-30. PubMed ID: 16097037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health profiles of 814 very long-term breast cancer survivors.
    Stava C; Weiss LT; Vassilopoulou-Sellin R
    Clin Breast Cancer; 2006 Aug; 7(3):228-36. PubMed ID: 16942639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symptoms and Symptom Attribution Among Women on Endocrine Therapy for Breast Cancer.
    Rosenberg SM; Stanton AL; Petrie KJ; Partridge AH
    Oncologist; 2015 Jun; 20(6):598-604. PubMed ID: 25933930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.